Download Advance Programme

EBCC
10
European
Breast Cancer
Conference
EBCCouncil
9 - 11 MARCH
2016
AMSTERDAM
THE NETHERLANDS
Isaac Israëls
Woman in profile in front of Van Gogh’s
sunflowers, 1917 (Oil on canvas – 71 x 59 cm)
Museum de Fundatie, Zwolle and Heino/Wijhe,
The Netherlands
Multidisciplinary Innovation
in Breast Cancer Care
Be part of a unique gathering of physicians,
scientists and patients.
Learn to apply the latest findings in a holistic way.
ADVANCE PROGRAMME
EBCC
10
European
Breast Cancer
Conference
Save the Dates
Registration deadlines
Early rate registration closes (receipt of payment by)
9 October 2015
Regular rate registration closes (receipt of payment by)
25 January 2016
For group registrations:
receipt of complete group participants’ details
25 January 2016
Late rate registration closes
Onsite rate registration
Accommodation booking closes
11 March 2016
as of 12 March 2016
9 January 2016
Submission deadlines
Regular abstract submission opens
15 August 2015
Regular abstract submission closes
4 November 2015
Fellowship grant application closes
4 November 2015
Late-breaking abstract submission opens
15 January 2016
Late-breaking abstract submission closes
22 January 2016
Conference Venue
Amsterdam RAI
Europaplein
1078 AZ Amsterdam
The Netherlands
Detailed information about the venue: www.rai.nl
ADVANCE PROGRAMME
Conference Secretariat
2
c/o ECCO – the European CanCer Organisation
Avenue E. Mounier 83
B-1200 Brussels
Tel: +32 2 775 02 01
Fax: +32 2 775 02 00
Email: [email protected]
Accreditation for Continuous Medical Education (CME)
Application for accreditation has been submitted to
the Accreditation Council of Oncology in Europe (ACOE).
Table of Contents
EBCC
10
European
Breast Cancer
Conference
Save the Dates2
Letter of Welcome4
Organising Partners5
Conference Committees7
Programme at a Glance10
Descriptions of Sessions13
Detailed Scientific and Workshop Programme14
Registration34
Call for Abstracts35
Fellowships & Grants36
Call for Nominations37
ADVANCE PROGRAMME
General Information38
3
EBCC
10
European
Breast Cancer
Conference
Letter of Welcome
The European Breast Cancer Conference in 2016 (EBCC-10) will take place in the
context of very tangible advances that have been made for patients in recent years.
These advances have been largely achieved through the successful application of a
multidisciplinary approach in the treatment and care of breast cancer.
EBCC is proud to have played its role in driving these advances for breast cancer
patients as a unique, dedicated multidisciplinary platform and the largest breast
cancer conference outside the US.
This edition of EBCC (EBCC-10) is again firmly based on a holistic vision of breast
cancer and brings together scientists, clinicians, patient representatives and health
professionals of diverse profiles to tackle key issues facing patients throughout the
continuum of the breast cancer journey. The conference programme will provide
the latest insights into the areas of prevention, optimal diagnosis, treatment,
survivorship, the advance driven by research in all of them so that EBCC again fulfills
its mission to accelerate the translation of clinical research into best practice made
widely available to patients all over Europe.
EBCC-10 will replicate the highly successful “Multidisciplinary Teams in the Real
World” and will have a strong focus on the work of the breast team throughout its
programme. Our aim is to strengthen the knowledge of different members of the
breast team as well as help ensure the optimal work of the team as a whole. The
conference registration fee structure has been designed specifically to support the
participation of breast teams.
The conference will again showcase practice-changing new data and provide
delegates with the opportunity to discuss it in sessions with innovative, interactive
formats.
EBCC-10 will highlight important regulatory developments in Europe. A European
Parliament resolution has stipulated that by 2016 member states should have
enshrined in law that all breast cancer patients are to be treated in a specialised
breast centre or unit. At EBCC-10, we will review the impact this resolution has had so
far on the treatment of breast cancer, we will map the status of its implementation
and discuss how best to direct our advocacy efforts in 2016 and beyond.
ADVANCE PROGRAMME
We look forward to welcoming you to Amsterdam on 9 – 11 March 2016: EBCC-10
awaits your active participation. Help us make it our best ever conference!
4
Fatima Cardoso
(Portugal)
Conference Chair
Roswitha Britz
(Spain)
Conference Co-Chair
Emiel Rutgers
(Netherlands)
National Organising
Committee Chair
Organising Partners
EBCC
10
European
Breast Cancer
Conference
European Breast Cancer Council
EBCCouncil
The European Breast Cancer Conferences are the responsibility of the not-for-profit
association European Breast Cancer Council (EBC Council). The European Breast
Cancer Council (EBC Council) is an association of European organisations involved
in breast cancer.
The three founding members of the organisation are EORTC Breast group, EUSOMA
and EUROPA DONNA. The mission of the Association is to raise awareness and
improve prevention, diagnosis, treatment and care of breast cancer patients.
Founding Members
EUROPA DONNA – The European Breast Cancer Coalition is an independent, nonprofit organisation whose members are affiliated groups from throughout Europe.
The coalition works to raise awareness of breast cancer and to mobilise the support
of European women in pressing for improved breast cancer education, appropriate
screening, optimal treatment and care and increased funding for research. EUROPA
DONNA represents the interests of European women regarding breast cancer to
local and national authorities as well as to institutions of the European Union.
The EORTC Breast Cancer Group is a multidisciplinary group of clinical researchers
and scientists involved in the development, coordination and implementation of
clinical and translational research, endeavouring to improve treatment of breast
cancer patients in Europe and beyond. The EORTC BCG has led and/or supported
studies that have changed clinical practice in the management of breast cancer,
including breast conservation, treatment of DCIS, management of the lymph nodes,
neo adjuvant chemotherapy etc..
ADVANCE PROGRAMME
For additional information on EUROPA DONNA please visit: www.europadonna.org
For additional information on the EORTC Breast Cancer Group please visit: www.eortc.org
5
EBCC
10
European
Breast Cancer
Conference
The European Society of Breast Cancer Specialists (EUSOMA) is a non-profit
organisation that promotes the multidisciplinary approach to breast cancer
diagnosis and treatment. Its members are specialists from across the spectrum of
professions involved in breast care. EUSOMA is committed to promoting interaction
between all the health professionals involved in breast cancer care with the aim of
ensuring that all patients with breast problems have equitable access to high quality
care delivered by specialist breast teams. EUSOMA is directly involved in setting
evidence based standards that form the basis for certification and accreditation of
breast centres and the clinical care that they provide.
ADVANCE PROGRAMME
EUSOMA achieves this by organising and participating in workshops and other scientific
meetings that consider current evidence that forms the basis for setting standards for
early detection, diagnosis, treatment and after care. In these meetings European experts
are invited in the different disciplines dedicated to Breast Cancer. These guidelines
and recommendations are disseminated throughout Europe. The EUSOMA guidelines
‘The requirements of a specialist breast centre’ are recognised as the current reference
document on the definition of breast centres and form the basis for Breast Centre
Certification. For additional information on EUSOMA please visit: www.eusoma.org
6
EBCC
10
Conference Committees
European
Breast Cancer
Conference
Organising Committee
Conference Chair
Conference Co-Chair
Chair EBCC-9
Chair EBCC-11
Chair National Organising Committee
Representatives EBC Council - vzw
Representatives EBC Council - vzw
F. Cardoso (Portugal)
R. Britz (Spain)
G. Viale (Italy)
R. Mansel (United Kingdom)
E. Rutgers (Netherlands)
D. Cameron (United Kingdom)
E. Bergsten-Nordstrom (Sweden)
Scientific Committee
Risk Factors
M. Schmidt
A. Salomon
G. Evans B. Borisch
Netherlands
France
United Kingdom
Switzerland
Step Team Leader
Member expert
Member expert
Member expert
Lifestyle/Prevention including Secondary Prevention
M. Broeders
J. Cuzick
A. Young
E. Bergsten Nordström
Netherlands
United Kingdom
United Kingdom
Sweden
Step Team Leader
Member expert
Member expert
Member expert
Italy
United Kingdom
Italy
Step Team Leader
Member expert
Member expert
Austria
Netherlands
Spain
Portugal
Netherlands
Greece
Italy
Step Team Leader
Member expert
Member expert
Member expert
Member expert
Member expert
Member expert
Optimal Diagnosis
F. Sardanelli
H. Dobson
S. Knox
M. Knauer
P. Poortmans I. Rubio
M. Cardoso
N. Russell
C. Markopoulos
A. Moreo
ADVANCE PROGRAMME
Local Regional Treatment
7
EBCC
10
European
Breast Cancer
Conference
Systemic Treatment
N. Harbeck
Germany
Step Team Leader
V. Dieras
France
Member expert
L. Biganzoli
Italy
Member expert
H. Bonnefoi
France
Member expert
S. Loibl
Germany
Member expert
N. Zernik
France
Member expert
Rehabilitation/Survivorship
R. Britz
Spain
Step Team Leader
D. Goddard
United Kingdom
Member expert
S. Schagen
Netherlands
Member expert
Y. Wengstrom
Sweden
Member expert
Follow up
M. Leidenius
M. Arnedos
R. Britz
Finland
France
Spain
Step Team Leader
Member expert
Member expert
Advanced Disease
O. Pagani
Switzerland
Step Team Leader
E. Senkus Poland
Member expert
H. Wildiers
Belgium
Member expert
E. Brain
France
Member expert
E. Papadopoulos
Cyprus
Member expert
Supportive and Palliative Care including end of life treatment
ADVANCE PROGRAMME
C. Ripamonti
Italy
Step Team Leader
M. Aapro
Switzerland
Member expert
T. Saarto
Finland
Member expert
S. Kyriakides
Cyprus
Member expert
8
Basic and Translational research
F. Andre
P. Dubsky
L. van ‘t Veer
W. Janni
J. Martens
F. Penault-Llorca
K. Benn
France
Austria
US
Germany
Netherlands
France
Italy
Step Team Leader
Member expert
Member expert
Member expert
Member expert
Member expert
Member expert
EBCC
10
European
Breast Cancer
Conference
National Organising Committee
E. Rutgers (Chair)
Netherlands Cancer Institute
Members
Maastricht University Medical Centre / Maastro Clinic
Netherlands Cancer Institute
Maastricht University Medical Centre
University Medical Centre Utrecht
Leiden University Medical Center
Netherlands Cancer Institute
University of California / Netherlands Cancer Institute
University Medical Centre Utrecht
Netherlands Cancer Institute
University Medical Centre Utrecht
Pink Ribbon Netherlands
BOOG Study Center
Europa Donna & Borstkanker Vereniging Nederland
KWF Kankerbestrijding
Borstkanker Vereniging Nederland
ADVANCE PROGRAMME
L. Boersma
S. Mook
M. Schmidt
E. van der Wall
J. van der Hoeven
J. Jonkers
L. van ’t Veer
R. Pijnappel
J. Wesseling
N. Wittebolle S. Veenhoff E. van Leeuwen-Stok E. Verschuur
M. Rudolphie
A. van Staa
9
EBCC
10
European
Breast Cancer
Conference
Programme at a Glance
Wednesday 9 March 2016
08:00
Partners in Breast Cancer Workshops
European Society of
Surgical Oncology
10:00
Senologic
European SocieTy
International
European Oncology
for Radiotherapy &
Society/International
Nursing Society
Oncology
School of Senology
Coffee Break
10:30
12:00
Poster Viewing
12:45
Opening Ceremony
including awards
13:30
Special Manifesto
Session
European Breast
Centres 2016: Impact
on mortality and
14:40
quality of life
14:45
Plenary Session
Keynote Lecture and
Tomorrow’s Practice
16:15 Changing Abstracts
Coffee Break and Poster Viewing
ADVANCE PROGRAMME
16:45
THBT Population
How to Communicate
Based Mammographic
the Diagnosis and
Screening Should be
Treatment Strategy
17:45
Stopped
17:45
18:45
18:30
20:00
10
Debate
Multidisciplinary
Team in the Real
World
Real World Forum
Style Your Life
Welcome Reception
Industry Session: Satellite Symposia
European Society
of Pathology
EBCC
10
European
Breast Cancer
Conference
Thursday 10 March 2016
07:00
Industry Session: Meet the Expert Breakfast Sessions
08:00
08:00
08:30
08:45
Teaching Lecture
Teaching Lecture
Teaching Lecture
Special Issues on the Management of
Elderly Breast Cancer Patients
Implementation of Oncoplastic
Surgery in Clinical Practice
Breast Cancer and Pregnancy
Teaching Lecture
Teaching Lecture
Teaching Lecture
Bone Health
Dignity Therapy
Are There New Standards for Adjuvant
09:15 Endocrine Therapy for Young Women?
Coffee Break and Poster Viewing
09:45
11:15
11:30
12:30
Clinical Science Symposium
Clinical Science Symposium
Clinical Science Symposium
Controversial Issues With the NeoAdjuvant Approach - including best
oral proffered paper(s)
Pain Management - including best oral
proffered paper(s)
Genes and Families - including best
oral proffered paper(s)
Best Oral Abstracts session
Multidisciplinary Team
in the Real World
Real World Forum
To be announced
Management of Breast Cancer in the
Neoadjuvant Setting
European Commission Initiative on
Breast Cancer
Poster Viewing
12:45
Industry Session: Satellite Symposia
13 :45
15:30
Clinical Science Symposium
Clinical Science Symposium
Luminal Breast Cancer - including best
Local Approaches for Metastases oral proffered paper(s)
including best oral proffered paper(s)
Coffee Break and Poster Viewing
16:00
Clinical Science Symposium
HER 2 Positive Breast Cancer 17:30 including best oral proffered paper(s)
18:30
20:00
Clinical Science Symposium
Clinical Science Symposium
Controversial Issues in Radiotherapy - Breast Density - How Thick is the Fog? including best oral proffered paper(s) including best oral proffered paper(s)
ADVANCE PROGRAMME
14:00
Industry Session: Satellite Symposia
11
EBCC
10
European
Breast Cancer
Conference
Friday 11 March 2016
07:00
Industry Session: Meet the Expert Breakfast Sessions
08:00
08:00
08:30
08:45
09:15
Teaching Lecture
Teaching Lecture
Real World Forum
Time of First Screening, a Life Changing Optimal Pathology for the Diagnosis of
Opportunity
Breast Cancer
Teaching Lecture
Teaching Lecture
Update on ABC3 Guidelines
Different Uses of Breast MRI
Survivorship and Social Economic
Issues for EBC and ABC Patients
08:00-09:15
Coffee Break and Poster Viewing
09:45
11:15
11:30
12:30
Plenary Session
Keynote Lecture and Today’s Practice
Changing Abstracts
Debate
THBT There are too Many
Mastectomies
Debate
Special Session
THBT only Breast Tissue Needs Regular Debate on Affordability and Access to
Follow Up
Cancer Care
Poster Viewing
12:45
Industry Session: Satellite Symposia
13 :45
14:00
Clinical Science Symposium
Clinical Science Symposium
What is new in the Biology of Breast
Triple Negative Breast Cancer (TNBC) Cancer? - including best oral proffered
including best oral proffered paper(s)
paper(s)
15:30
ADVANCE PROGRAMME
15:45
12
16:45
16:30
17:30
Clinical Science Symposium
The New Mammography - including
best oral proffered paper(s)
Multidisciplinary Team
in the Real World
Real World Forum
Advanced Breast Cancer
How to Manage Side Effects of
Treatment
Plenary Session
Take Home Messages and Closure
Descriptions of Sessions
EBCC
10
European
Breast Cancer
Conference
Debates
Debates should follow an Oxford style format. A controversial topic is introduced,
scientifically challenging a proposer and an opponent to the motion, and opened for
debate with the audience.
At the end of the session, the audience takes an informal vote.
Plenary Session
Plenary sessions will include a keynote lecture of an eminent speaker in the field of
breast cancer as well as Late Breaking and New Data abstracts.
Multidisciplinary Team in the Real world session
MTR Panels are interactive and addressing topical subjects comprising a moderator
and expert panel representing various disciplines.
The Multidisciplinary Team in the real world is an interactive session where a clinical
case will be presented followed by an open discussion between the audience and
the panel of experts.
Clinical Science Symposium
A Clinical Science Symposium is focused on a topic/theme followed all the way
through; research presentations for instance are to include the latest perspectives of
basic, translational and clinical research issues in a specific field.
The session provides a forum for presentations followed by high level scientific
discussion of the different research areas and best oral abstract(s).
Teaching Lectures
Teaching Lectures are state-of-the-art lectures and give an overview of the latest
developments in the field of breast cancer. This lecture is given by a well-known
expert who has the ability to captivate the audience’s attention regarding the future
of cancer treatment and care.
Special Manifesto Session
The manifesto is a statement document prepared by the European Breast Cancer
Council working group and launched at the European Breast Cancer Conference in
Amsterdam.
Partners in Breast Cancer Workshops
Societies have been invited to compile Breast Cancer Workshop Programmes related
to their field.
Real World Forum
These are sessions focusing on significant “real world” issues and topics of interest to
all participants. Perspectives of patient advocates, scientists, medical professionals,
policy and other experts will be presented.
ADVANCE PROGRAMME
Opening Session
The Opening Session will include the European Breast Cancer Science Award
(Emmanuel van der Schueren Lecture) and The European Breast Cancer Arts and
Humanities Award.
13
EBCC
10
European
Breast Cancer
Conference
Detailed Scientific and Workshop
Programme
Wednesday 9 March 2016
Updated information is available on the searchable programme
– see www.ecco-org.eu/Events/EBCC10
European Society of Surgical Oncology
Workshop
08:00 - 12:00
Chair: R.A. Audisio (United Kingdom)
LIQUID BIOPSIES AND PRECISION SURGERY
Liquid biopsy: Today and tomorrow
Speaker: D. Peeters (Belgium)
DCIS: Molecular subtypes and individualised prognosis
Speaker: W. Zhou (Sweden)
Risk adapted breast cancer screening
Speaker: L. Esserman (USA)
Circulating tumour cells and metastatic breast cancer
Speaker: F. Bidard (France)
Questions and Answers
Coffee break
ADVANCED MANAGEMENT OF HER2 3+ TUMOURS
Value of tumor-infiltrating lymphocytes in neoadjuvant treatment:
Involvement in prognosis and pathologic complete response
Speaker: C. Criscitiello (Italy)
Guided breast conservative surgery in clinical complete response
after neoadjuvant treatments
ADVANCE PROGRAMME
Speaker: I.T. Rubio (Spain)
14
Fertility preservation
Speaker: L. Del Mastro (Italy)
How genomic profiling may change the status of HER2 3+ tumours
Speaker: L. J. Van ‘t Veer (USA)
Questions and Answers
EBCC
10
European
Breast Cancer
Conference
European SocieTy for Radiotherapy and Oncology
Workshop: Accelerated Partial Breast Irradiation:
Current Status and Perspectives
08:00 - 12:00
Chair: B. Offersen (Denmark)
Chair: D. Gabrys (Poland)
SESSION I
Are we treating the disease we think we are?
Speaker: D. Gabrys (Poland)
GEC-ESTRO consensus guideline for target delineation in partial
breast irradiation
Speaker: V. Strnad (Germany)
TARGIT-A Trial
Speaker: F. Wenz (Germany)
Results from the ELIOT Trial
Speaker: R. Orecchia (Italy)
Panel discussion: What are the optimal patient selection criteria for
APBI? Can RT be safely withheld in selected patients?
Coffee break
SESSION II
Longterm results of the phase III GEC-ESTRO APBI trial
Speaker: C. Polgár (Hungary)
Results from the phase III randomised trial IMPORT-LOW
Speaker: C.E. Coles (United Kingdom)
Results from the randomised DBCG PBI Trial
ADVANCE PROGRAMME
Speaker: B. Offersen (Denmark)
Panel discussion: Is APBI ready for prime time? What is the
optimal strategy? What can we learn about volume effects and
fractionation?
15
EBCC
10
European
Breast Cancer
Conference
SIS/ISS - Senologic International Society/ International
School of Senology: Conceptual Highlights in Benign
and Invasive Breast Disease
08:00 - 12:00
Chair: T. Pienkowski (Poland)
Chair: R. Orda (Israel)
PART I - BENIGN BREAST DISEASE
Welcoming remarks
Speaker: A. Mundinger (Germany)
Which life style columns prevail over breast cancer risk?
Speaker: C. Mathelin (France)
Modern imaging techniques at the edge — benign vs. malignant?
Speaker: A. Mundinger (Germany)
Unusual breast disease and the art of cosmetic surgery
Speaker: M. Magalhães Costa (Brazil)
The international initiative on accrediting breast centres
Speaker: R. Orda (Israel)
Roundtable discussion
Coffee break
Chair: A. Mundinger (Germany)
Chair: D. Tripathy (USA)
PART II - PRE-INVASIVE AND INVASIVE BREAST DISEASE
New frontiers of imaging DCIS
Speaker: A. Mundinger (Germany)
ADVANCE PROGRAMME
Highlights in surgical treatment of DCIS
Speaker: S. Schneebaum (Israel)
Pros and cons on chemoprophylaxis of pre-invasive lesions
Speaker: T. Pienkowski (Poland)
Translating genetic drivers into new targeted therapies for breast
cancer
Speaker: D. Tripathy (USA)
Closing remarks
Speaker: T. Pienkowski (Poland)
16
EBCC
10
European
Breast Cancer
Conference
European Oncology Nursing Society Workshop:
The Impact of Breast Cancer on Patients and
Caregivers
08:00 - 12:00
Chair: Y. Wengström (Sweden)
Chair: N. De Beer (Netherlands)
AGE SPECIFIC ITEMS
Chemotherapy and pregnancy; the impact on caregivers?
Speaker: K. Van Calsteren (Belgium)
Intimacy and sexuality during treatment - age specific?
Speaker: C. Eeltink (Netherlands)
Geriatric assessment - optional or mandatory?
Speaker in favour: A. Speelman (Netherlands)
Speaker against: E. Brain (France)
Discussion with audience
Moderator: N. De Beer (Netherlands)
Coffee break
TRANSITION IN THE PALLIATIVE PHASE
Shared decision making during palliative treatment - The do’s and
dont’s in a conversation
Speaker: M. Baas (Netherlands)
How are you handling death?
Speaker: B. Buizert (Netherlands)
ADVANCE PROGRAMME
Question and Answers
17
EBCC
10
European
Breast Cancer
Conference
European Society of Pathology Workshop: Optimal Pathology Characterization of Invasive Breast
Cancer 2016
08:00 - 12:00
Chair: T. Tot (Sweden)
Chair: A. Sapino (Italy)
Introduction: EBCC Glasgow Optimal Pathology Manifesto
Speaker: T. Tot (Sweden)
Radiological – pathological correlation, a must
Speaker: T. Tot (Sweden)
The role of tumour typing and grading
Speaker: M.P. Foschini (Italy)
Problems in determining the tumours’ molecular phenotype
Speaker: A. Sapino (Italy)
Tumor heterogeneity, a real complication
Speaker: G. Pekar (Sweden)
Coffee break
Diagnosing metastatic disease
Speaker: G. Cserni (Hungary)
Molecular genetic tools in routine diagnosis
Speaker: P.J. Van Diest (Netherlands)
Discussion
Conclusions
Speaker: T. Tot (Sweden)
ADVANCE PROGRAMME
Poster Viewing
18
12:00-12:45
EBCC
10
European
Breast Cancer
Conference
Opening Ceremony: 10th European Breast Cancer
Conference
12:45 - 13:30
WELCOME ADDRESS
Conference Chair
Chair: F. Cardoso (Portugal)
Conference Co-Chair
Chair: R. Britz (Spain)
National Organising Committee Chair
Chair: E.J.T. Rutgers (Netherlands)
THE EBCC ARTS AND HUMANITIES AWARD
Chair: R. Britz (Spain)
The European Breast Cancer Arts and Humanities Award
Awardee: To be announced
The EBCC Arts and Humanities Award will be presented to the individual who has
‘made a difference’ through an artistic or humanistic activity such as artwork,
dance, film, literature, music photography or poetry and whose contribution
and personal achievements reflect the efforts and vision that unites EBCC
THE EUROPEAN BREAST CANCER SCIENCE AWARD
Chair: F. Cardoso (Portugal)
Emmanuel van der Schueren Lecture
Breast Centres in Europe: Will 2016 be remembered?
ADVANCE PROGRAMME
Award Lecturer: L. Cataliotti (Italy)
19
EBCC
10
European
Breast Cancer
Conference
Special Manifesto Session: European Breast Centres
2016 - Impact in Mortality and Quality of Life
13:30 - 14:40
Chair: F. Cardoso (Portugal)
Chair: E.J.T. Rutgers (Netherlands)
The Belgian experience
Speaker: F. Liebens (Belgium)
The German experience
Speaker: S. Wesselmann (Germany)
The Dutch experience
Speaker: M.J. Vrancken - Peeters (Netherlands)
EU Survey - European Breast Centres in 2016: Where are we?
Speaker: D. Lerda (Italy)
Panel discussion
Moderator: F. Cardoso (Portugal)
Panel:
K. Benn (Italy)
E.J.T. Rutgers (Netherlands)
D. Lerda (Italy)
M.J. Vrancken - Peeters (Netherlands)
S. Wesselmann (Germany)
F. Liebens (Belgium)
A. Costa (Italy)
L. Cataliotti (Italy)
S. Kyriakides (Cyprus)
D.A. Cameron (United Kingdom)
Plenary Session: Keynote Lecture and Tomorrow’s
Practice Changing Abstracts
ADVANCE PROGRAMME
14:45 - 16:15
Chair: To be announced
Beyond sequencing the cancer genome
Keynote Speaker: R. Bernards (Netherlands)
Tomorrow’s practice changing abstracts
Poster Viewing
16:15-16:45
20
EBCC
10
European
Breast Cancer
Conference
Debate: This House Believes That Population Based
Mammographic Screening Should be Stopped
16:45 - 17:45
Moderator: S. Kyriakides (Cyprus)
Speaker in favour: P. Gotzsche (Denmark)
Speaker against: M. Untch (Germany)
Seconder in favour: P. Zahl (Norway)
Seconder against: H. J. De Koning (Netherlands)
Discussion & Voting
Multidisciplinary Team in the Real World: How to
Communicate the Diagnosis and Treatment Strategy
16:45 - 17:45
Moderator: R.E. Mansel (United Kingdom)
Case presentation:
Speaker: L. Elshof (Netherlands)
Panel:
Y. Wengström (Sweden) (Nurse)
G. Jerusalem (Belgium) (Medical oncologist)
D. Razavi (Belgium) (Psycho-oncology)
K. Benn (Italy) (Patient advocate)
F. Sardanelli (Italy) (Radiologist)
Real World Forum: Style Your Life
16:45 - 17:45
Chair: A. Anderson (United Kingdom)
Chair: S. Knox (Italy)
Speaker: M. Pollan (Spain)
Changing lifestyle behaviour for breast cancer prevention
Speaker: A. Anderson (United Kingdom)
Promoting breast health before and after breast cancer
Speaker: S. Knox (Italy)
Current evidence on the impact of lifestyle factors on breast cancer
Speaker: I. Romieu (France)
ADVANCE PROGRAMME
Obesity and breast cancer
21
EBCC
10
European
Breast Cancer
Conference
Thursday 10 March 2016
Teaching Lecture: Special Issues on the Management of
Elderly Breast Cancer Patients
08:00 - 08:30
Chair: H. Wildiers (Belgium)
Speaker: E. Brain (France)
Teaching Lecture: Implementation of Oncoplastic
Surgery in Clinical Practice
08:00 - 08:30
Chair: B. Carly (Belgium)
Speaker: M.J. Cardoso (Portugal)
Teaching Lecture: Breast Cancer and Pregnancy
08:00 - 08:45
Chair: F.A. Peccatori (Italy)
Speaker: H. Azim jr (Belgium)
Teaching Lecture: Are There New Standards for
Adjuvant Endocrine Therapy for Young Women?
08:45 - 09:15
Chair: I. Smith (United Kingdom)
Speaker: O. Pagani (Switzerland)
Teaching Lecture: Bone Health
ADVANCE PROGRAMME
08:45 - 09:15
22
Chair: S. Aebi (Switzerland)
Speaker: P. Hadji (Germany)
Teaching Lecture: Dignity Therapy
08:45 - 09:15
Chair: G. Abela (Malta)
Speaker: To be announced
EBCC
10
European
Breast Cancer
Conference
Poster Viewing
09:15-09:45
Clinical Science Symposium: Controversial Issues With
the Neo-Adjuvant Approach
09:45 - 11:15
Chair: E.J.T. Rutgers (Netherlands)
Chair: N. Bese (Turkey)
Management of lymph nodes - what to do
Speaker: T. Kühn (Germany)
Extent of breast surgery
Speaker: M. Knauer (Switzerland)
Optimal radiological and molecular assessment
Speaker: T. Helbich (Austria)
Molecular characterisation of residual disease
Speaker: E. Provenzano (United Kingdom)
Oral proffered paper abstracts
Clinical Science Symposium: Pain Management
09:45 - 11:15
Chair: S. Schagen (Netherlands)
Chair: D. Fenech (Malta)
The assessment of pain
Speaker: M. Aapro (Switzerland)
Neuropathic pain
Speaker: M. Fallon (United Kingdom)
Speaker: D. Santini (Italy)
Pain due to oncology treatment
Speaker: C. Ripamonti (Italy)
Oral proffered paper abstracts
ADVANCE PROGRAMME
Bone pain
23
EBCC
10
European
Breast Cancer
Conference
Clinical Science Symposium: Genes and Families
09:45 - 11:15
Chair: M.K. Schmidt (Netherlands)
Chair: B. Borisch (Switzerland)
Valid risk predictions and which genes to screen
Speaker: D. Easton (United Kingdom)
NGS- a solution for all?
Speaker: E. Levy-Lahad (Israel)
Breast cancer families without hereditary variants- what to do?
Speaker: R. Schmutzler (Germany)
Consequences for the clinic
Speaker: C. Singer (Austria)
Oral proffered paper abstracts
Multidisciplinary Team in the Real World: Management
of Breast Cancer in the Neoadjuvant Setting
11:30 - 12:30
Moderator: S. Delaloge (France)
Case presentation
Speaker: K. Tryfonidis (Belgium)
ADVANCE PROGRAMME
Panel:
S. Erdem (Turkey) (Patient advocate)
A. Di Leo (Italy) (Medical oncologist)
A. Costa (Italy) (Surgeon)
L. Moser (Portugal) (Radiation oncologist)
G. Pruneri (Italy) (Pathologist)
24
EBCC
10
European
Breast Cancer
Conference
Real World Forum: European Commission Initiative on
Breast Cancer
11:30 - 12:30
Chair: R. Britz (Spain)
Chair: R.E. Mansel (United Kingdom)
The Commission’s perspective
Speaker: To be announced
Guideline development group for EU guidelines revision
Speaker: To be announced
Quality assurance scheme development group for breast services
Speaker: To be announced
Patient advocate perspective
Speaker: To be announced
Poster Viewing
12:30-14:00
Clinical Science Symposium: Luminal Breast Cancer
14:00 - 15:30
Chair: L. Biganzoli (Italy)
Chair: B. Sousa (Portugal)
Luminal breast cancer, more than two diseases?
Speaker: W. Zwart (Netherlands)
Find the balance between over and under treatment
Speaker: D.A. Cameron (United Kingdom)
Endocrine and targeted agents as the new standard of care
Speaker: F. André (France)
Oral proffered paper abstracts
ADVANCE PROGRAMME
Speaker: V. Dieras (France)
Selection of patients for CDK/mTOR inhibitors?
25
EBCC
10
European
Breast Cancer
Conference
Clinical Science Symposium: Local Approaches for
Metastases
14:00 - 15:30
Chair: D. Zardavas (Belgium)
Chair: B. Linderholm (Sweden)
How to select patients
Speaker: E. Senkus (Poland)
Brain metastases
Speaker: M.J. Van den Bent (Netherlands)
Visceral metastases
Speaker: K. Gelmon (Canada)
Surgery of the primary tumour
Speaker: P. Dubsky (Austria)
Can we predict and prevent specific sites of metastases?
Speaker: R. Gomis (Spain)
Oral proffered paper abstracts
Poster Viewing
15:30-16:00
Clinical Science Symposium: HER 2 Positive Breast
Cancer
16:00 - 17:30
Chair: A. Gennari (Italy)
Chair: H. Bonnefoi (France)
HER 2 Positive Breast Cancer: still a single disease?
ADVANCE PROGRAMME
Speaker: N. Harbeck (Germany)
Optimal sequencing of anti-HER2-based therapy
Speaker: E. Winer (USA)
How to overcome resistance to anti-HER-2 agents
Speaker: S. Loi (Australia)
How women cope with HER-2
Speaker: M. Miklavcic (Slovenia)
Oral proffered paper abstracts
26
EBCC
10
European
Breast Cancer
Conference
Clinical Science Symposium: Controversial Issues in
Radiotherapy
16:00 - 17:30
Chair: A. Moreo (Italy)
Chair: N.S. Russell (Netherlands)
When are lymph nodes a target?
Speaker: P. Poortmans (Netherlands)
Timing of radiotherapy and reconstruction
Speaker: L. Moser (Portugal)
Is radiotherapy for all DCIS?
Speaker: B. Chua (Australia)
Is biological-driven radiotherapy possible?
Speaker: L. Pierce (USA)
Oral proffered paper abstracts
Clinical Science Symposium: Breast Density - How Thick
is the Fog?
16:00 - 17:30
Chair: D. Goddard (United Kingdom)
Chair: M. Christiaens (Belgium)
What women should or should not know about breast density
Speaker: E. Bergsten-Nordstrom (Sweden)
How to measure breast density
Speaker: A. Tagliafico (Italy)
Breast density as a masking factor
Speaker: U. Bick (Germany)
Speaker: C. Colin (France)
Tamoxifen for breast density
Speaker: L. J. Van ‘t Veer (USA)
Oral proffered paper abstracts
ADVANCE PROGRAMME
Breast density as a questionable prognostic factor
27
EBCC
10
European
Breast Cancer
Conference
Friday 11 March 2016
Teaching Lecture: Time of First Screening, a Life
Changing Opportunity
08:00 - 08:30
Chair: M. Broeders (Netherlands)
Speaker: P. Hall (Sweden)
Teaching Lecture: Optimal Pathology for the Diagnosis
of Breast Cancer
08:00 - 08:30
Chair: M. Fernö (Sweden)
Speaker:G. Viale (Italy)
Real World Forum: Survivorship and Social Economic
Issues for EBC and ABC Patients
08:00 - 09:15
Chair: L.D. Shockney (USA)
Chair: N. Zernik (France)
Back to work
Speaker: I. Lebrocquy (Netherlands)
Breast cancer survivors-uninsurable
Speaker: E. Bergsten-Nordstrom (Sweden)
Daily life support
Speaker: L.D. Shockney (USA)
Psycho-social support: What’s new?
ADVANCE PROGRAMME
Speaker: L. Fallowfield (United Kingdom)
28
A patient experience: How to navigate in stormy waters
Speaker: E. Papadopoulos (Cyprus)
Teaching Lecture: Update on ABC3 Guidelines
08:45 - 09:15
Chair: S. Paluch-Shimon (Israel)
Speaker: F. Cardoso (Portugal)
EBCC
10
European
Breast Cancer
Conference
Teaching Lecture: Different Uses of Breast MRI
08:45 - 09:15
Chair: E. Verschuur-van der Voort (Netherlands)
Speaker: F. Sardanelli (Italy)
Poster Viewing
09:15-09:45
Plenary Session: Keynote Lecture and Today’s Practice
Changing Abstracts
09:45 - 11:15
Chairs: To be announced
To be announced
Keynote Speaker: to be announced
Today’s practice changing abstracts
Debate: This House Believes that There are Too Many
Mastectomies
11:30 - 12:30
Moderator: D.A. Cameron (United Kingdom)
Speaker in favour: M.J. Cardoso (Portugal)
Speaker against: M. Gnant (Austria)
Seconder in favour: I.T. Rubio (Spain)
Seconder against: M. Rezai (Germany)
Debate: This House Believes that Only Breast Tissue
Needs Regular Follow Up
11:30 - 12:30
Moderator: M. Aapro (Switzerland)
Speaker in favour: M. Leidenius (Finland)
Seconder in favour: F. Gilbert (United Kingdom)
Speaker against: J. Bergh (Sweden)
Seconder against: E. Bergsten-Nordstrom (Sweden)
ADVANCE PROGRAMME
Discussion & Voting
Discussion & Voting
29
EBCC
10
European
Breast Cancer
Conference
Special Session: Debate on Affordability and Access to
Cancer Care
11:30 - 12:30
Chair: F. Cardoso (Portugal)
Affording Effective Prevention, Treatment and Care – Breast Cancer
in the 21st Century
Speaker: D.G. Taylor (United Kingdom)
Panel discussion
Moderator: F. Cardoso (Portugal)
N. Harbeck (Germany) (Gynaecologist)
C. Jommi (Italy) (Policy analysis and public management)
S. Kyriakides (Cyprus) (Patient advocate)
To be announced (Health care)
A. Eniu (Romania) (Medical oncologist)
C. Markopoulos (Greece) (Medical oncologist)
N. El Saghir (Lebanon) (Medical oncologist)
To be announced (Pharma)
Poster Viewing
12:30-14:00
Clinical Science Symposium: Triple Negative Breast
Cancer (TNBC)
14:00 - 15:30
Chair: M. Piccart (Belgium)
Chair: C. Drukker (Netherlands)
Triple negative breast cancer: Still an entity in 2016?
ADVANCE PROGRAMME
Speaker: C. Caldas (United Kingdom)
30
Time to change the standard?
Speaker: S. Loibl (Germany)
Metastatic TNBC: Anything beyond chemotherapy?
Speaker: A. Tutt (United Kingdom)
Oral proffered paper abstracts
EBCC
10
European
Breast Cancer
Conference
Clinical Science Symposium: What is New in the Biology
of Breast Cancer?
14:00 - 15:30
Chair: F. Penault-Llorca (France)
Chair: J.W. Martens (Netherlands)
Technical approach: Biopsies vs CTC vs circulating nucleic acids
Speaker: W. Janni (Germany)
Genomic landscape of metastatic breast cancer
Speaker: M. Arnedos (France)
Is it possible to identify genetic determinants of lethal breast
cancers?
Speaker: D. Cox (France)
Stem cells: Stem cell targeting
Speaker: R. Clarkson (United Kingdom)
Oral proffered paper abstracts
Clinical Science Symposium: The New Mammography
14:00 - 15:30
Chair: F. Sardanelli (Italy)
Chair: E. Tomberg (Estonia)
Tomosynthesis for screening
Speaker: P. Skaane (Norway)
Tomosynthesis for diagnosis
Speaker: R. Pijnappel (Netherlands)
Contrast enhanced mammography
Speaker: E. Fallenberg (Germany)
Speaker: M. Wallis (United Kingdom)
Oral proffered paper abstracts
ADVANCE PROGRAMME
Photon counting
31
EBCC
10
European
Breast Cancer
Conference
Multidisciplinary Team in the Real World: Advanced
Breast Cancer
15:45 - 16:45
Moderator: A. Eniu (Romania)
Case presentation
Speaker: J. Ribeiro (Portugal)
Panel:
H. Wildiers (Belgium) (Medical oncologist)
C. Vrieling (Switzerland) (Radiation oncologist)
E. Papadopoulos (Cyprus) (Patient advocate)
R. Rouzier (France) (Surgeon)
N. West (United Kingdom) (Nurse)
T. Saarto (Finland) (Medical oncologist)
Real World Forum: How to Manage Side Effects of
Treatment
15:45 - 16:45
Chair: M. Miklavcic (Slovenia)
Chair: M. Ignatiadis (Belgium)
Use of complementary medicine
Speaker: D. Barton (USA)
Use of exercise
Speaker: O. Gentilini (Italy)
Cognitive function
Speaker: S. Schagen (Netherlands)
Fatigue
Speaker: F. Roila (Italy)
ADVANCE PROGRAMME
Depression
32
Speaker: S. Higgins (Ireland)
Questions and Answers
EBCC
10
European
Breast Cancer
Conference
Plenary Session: Take Home Messages and Closure
16:30 - 17:30
Chair: F. Cardoso (Portugal)
Chair: R. Britz (Spain)
Chair: E.J.T. Rutgers (Netherlands)
Take home messages for early breast cancer
Speaker: A. Di Leo (Italy)
Take home messages for advanced breast cancer
Speaker: K. Gelmon (Canada)
The patient advocate perspective
Speaker: R. Britz (Spain)
Closure
ADVANCE PROGRAMME
Speaker: F. Cardoso (Portugal)
33
EBCC
10
European
Breast Cancer
Conference
Registration
Register online at: www.ecco-org.eu/EBCC10
Registration Fees
Register early to attend EBCC10 - The European Breast Cancer Conference - and
benefit from significant savings of fees.
It is our priority to make the Conference accessible to all groups who contribute
their perspectives to the impressive progress in breast cancer treatment and care.
Our rates are designed to facilitate the attendance of diverse professionals, patient
advocates and students.
Special registration incentive for Breast Cancer Teams: 1 free registration is
offered upon registration of 3 (three) participants with different professional profiles
from the same work place.
Early Rate – deadline: 9 October 2015
Physicians (Surgical Oncologists, Medical Oncologists, Radiation
Oncologists, Gynaecologists, Pathologists, Imaging specialists, Geneticists,
GPs)
€505
Industry (Public affairs, regulatory, medical affairs)
€505
Care givers (clinical, community, hospital & oncology pharmacists, nurses,
palliative care specialists, rehabilitation specialists, psychologists)
€250
Researchers (Epidemiologists, Scientists, Data managers, Biostatisticians)
€250
Emerging Economy***
€150
Patient Advocates*
€125
Students**
€125
ADVANCE PROGRAMME
Regular Rate – deadline: 25 January 2016
34
Physicians (Surgical Oncologists, Medical Oncologists, Radiation
Oncologists, Gynaecologists, Pathologists, Imaging specialists, Geneticists,
GPs)
€745
Industry (Public affairs, regulatory, medical affairs)
€745
Care givers (clinical, community, hospital & oncology pharmacists, nurses,
palliative care specialists, rehabilitation specialists, psychologists)
€510
Researchers (Epidemiologists, Scientists, Data managers, Biostatisticians)
€510
Patient Advocates*
€175
Students**
€175
Late Rate – as of 26 January 2016
Physicians (Surgical Oncologists, Medical Oncologists, Radiation
Oncologists, Gynaecologists, Pathologists, Imaging specialists, Geneticists,
GPs)
€875
Industry (Public affairs, regulatory, medical affairs)
€875
Care givers (clinical, community, hospital & oncology pharmacists, nurses,
palliative care specialists, rehabilitation specialists, psychologists)
€650
Researchers (Epidemiologists, Scientists, Data managers, Biostatisticians)
€650
Patient Advocates*
€300
Students**
€300
EBCC
10
European
Breast Cancer
Conference
Optional Social Event*** €65.
The day registration rate of €350 per person will open at the venue only, as of 8 March 2016.
* The patient advocate rate applies exclusively for individuals who are a member of Patient Advocacy
Organisation.
** Confirmation in ‘training’ status from the Head of Department is required.
*** Emerging Economy rate applies to individuals from low and lower-middle-income economies
according to the World Bank listing. http://data.worldbank.org/about/country-and-lending-groups
**** This ticket gives access to the social event held on Thursday 10 March 2016.
Call for Abstracts
EBCC is instrumental in driving advances for breast cancer patients as a unique,
dedicated multidisciplinary platform and the largest breast cancer conference
outside the US. It traditionally attracts ground-breaking, practice-changing data and
it has a global outreach through the number of journalists attending the meeting.
•
Abstracts submitted after the stipulated deadline will not be considered.
•
Authors are strongly advised to submit prior to the deadline and avoid unnecessary
delays which may affect the standing of their abstract.
•
For more information on abstract topics, format, submission and selection process,
please visit the Congress website: www.ecco-org.eu/EBCC10
Regular Abstracts
Abstract submission open:
Abstract submission deadline:
15 August 2015
4 November 2015, 21:00 Central European Time
Late-Breaking Abstracts
Abstract submission open: Abstract submission deadline: 15 January 2016
22 January 2016, 21:00 Central European Time
Please note that the late-breaking abstract deadline is not an extension of the regular
abstract submission deadline.
ADVANCE PROGRAMME
The presenting author will receive confirmation of acceptance or rejection by mid
December 2015
The presenting author will receive confirmation of acceptance or rejection by the
beginning of February 2016.
35
EBCC
10
European
Breast Cancer
Conference
Fellowships & Grants
Europa Donna Fellowship Grants
The Organising Committee will award five Europa Donna fellowships to breast
cancer advocates.
To be considered for a Europa Donna Fellowship the following criteria should apply:
1.
2.
3.
4.
breast cancer survivor
under the age of 40 years
fluent in English
demonstrated some involvement in breast cancer advocacy work for at least
one year
To apply:
The individual must provide a short abstract (400 words) about your current
advocacy activities and indicate why EBCC-10 will be important to your future
advocacy work. This paper should be submitted to the Head Office of EUROPA
DONNA for the Board to review.
Each fellowship grant shall be worth a free registration, free accommodation for a
maximum of 3 nights and reimbursement of travel costs up to a maximum of
500 EUR (reimbursement after the conference).
Applicants who meet the above criteria should send their abstracts to:
EUROPA DONNA - The European Breast Cancer Coalition
Piazza Amendola 3
20149 Milan, Italy
Tel: +39 02 3659 2280
Fax: +39 02 3659 2284
[email protected]
Deadline for receipt of applications is
14 September 2015
ADVANCE PROGRAMME
The applications will be reviewed by the Europa Donna Board and EBCC-10 Scientific
Executive Committee. Successful applicants will be notified in January 2016.
36
EBCC
10
Call for Nominations
European
Breast Cancer
Conference
The European Breast Cancer Arts and Humanities Award
The Organising Committee of the 10th European Breast Cancer Conference invites
nominations for the EBCC Arts and Humanities Award, a prize that recognizes an
outstanding contribution to the arts/humanities and which has a direct relationship
to the fight against breast cancer.
The EBCC Arts and Humanities Award will be awarded to the individual who has
“made a difference” through an artistic or humanistic activity such as: artwork,
dance, film, literature, music, photography or poetry and whose contribution and
personal achievements reflect the efforts and vision that unites EBCC.
It is important that such efforts do not go unrecognized, thus we invite you to look
within your respective countries and nominate an individual whom you believe
deserves this significant recognition on the occasion of the 10th European Breast
Cancer Conference in Amsterdam.
The EBCC Arts and Humanities Award is worth 1,500 EUR and includes an allexpenses- paid trip to attend EBCC-10.
Please submit your nomination directly to:
EUROPA DONNA- The European Breast Cancer Coalition
Piazza Amendola, 3
20149 Milan- Italy
tel. +39 02 3659 2280
fax. +39 02 3659 2284
[email protected]
Nominations must be received by
1 December 2015
EBCC-10 Fellowship Grants
Fellowship submission open: Fellowship submission deadline: 15 August 2015
4 November 2015, 21:00 Central European Time
For submission of your fellowship application please go to: www.ecco-org.eu/EBCC10
The Organising Committee will award a number of fellowship grants to young
doctors, basic scientists, nurses and others involved in breast cancer care and
advocacy, from developing countries to attend the European Breast Cancer
Conference in Amsterdam. (Applied to individuals from low-income and lowermiddle-income economies according to the World Bank listing available at: http://
data.worldbank.org/about/country-classifications/country-and-lending-groups)
Fellowship for individuals from limited resources countries
The Organising Committee will award a number of fellowship grants to young doctors,
basic scientists, nurses and others involved in breast cancer care and advocacy, from
countries with limited resources to attend the European Breast Cancer Conference in
Amsterdam.
ADVANCE PROGRAMME
Fellowship for individuals from developing countries
37
EBCC
10
European
Breast Cancer
Conference
General Information
Accommodation
Amsterdam RAI Hotel & Travel Service has been appointed as the official local
housing partner for EBCC-10 and is offering hotel accommodation for both groups
and individuals.
For all accommodation queries and information, please visit: www.rai.nl/hotelservice
For questions, please contact: [email protected] or tel: +31 (0)20 549 1927. We kindly
ask you to contact the appointed local housing partner directly. The Conference
secretariat cannot provide accommodation-related information or handle any such
related requests.
Accommodation reservation deadline:
9 January 2016
Exhibition & Sponsorship
The recognised multidisciplinary setting of EBCC-10 will once again provide ideal
surroundings for participants to leverage knowledge, promote education and build
awareness about breast cancer – placing the patient at the heart of all our efforts
and discussions. The Conference strives to further the role of multidisciplinary
oncology in breast cancer by encouraging participation and interaction between all
oncology professions.
For information on sponsorship and exhibition opportunities, please contact: Bruno
De Man, tel: +32 2 775 02 04, email: [email protected].
The Invitation to Industry brochure and exhibition floor plan will be published on
the Conference website: http://www.ecco-org.eu/Events/EBCC10.
Insurance
The organisers do not accept liability for individual medical, travel or personal
insurance. Participants are strongly encouraged to make their own arrangements
regarding health and travel insurance.
ADVANCE PROGRAMME
Language and Translation
The official language of the Conference is English. No simultaneous translation will
be provided.
Lunch and Refreshments
Coffee breaks courtesy of the organisers will be scheduled during the Conference.
Delegates are invited to buy their own luncheons from the cash-bars located
throughout the Conference centre. Please note that only payment in euro is
accepted.
Free water dispensers are available throughout the Conference centre.
38
EBCC
10
European
Breast Cancer
Conference
EBCC Networking Evening
A Unique Venue for a Warm and Friendly Networking Evening
This evening is organised for Conference delegates as an opportunity for even more
memorable interactions among peers from different areas in oncology. It will take
place at the National Maritime Museum. Completely renovated, the Museum exudes
history in its impressive, refreshed glory. During the EBCC networking evening, the
Museum will be the centre of lively exchange among Conference delegates in a
warm atmosphere of memorable hospitality.
Tickets will be available for purchase at the time of registration for the Conference.
Availability of tickets on site may be limited so purchase at registration is highly
recommended.
The Bulletin
The Bulletin is the official e-newsletter of EBCC-10. Designed specifically to help keep
you fully informed about the latest scientific programme highlights and exciting
developments in the lead up to the Conference. Launching six months in advance of
the Conference, this monthly newsletter is sent to all registrants and appears on the
Conference website: www.ecco-org.eu/EBCC10.
If you wish to subscribe, please visit www.ecco-org.eu and create an account.
Participants registered for the entire duration of the EBCC-10 Conference are entitled
to one free public transport ticket giving access to public transport in Amsterdam
throughout the event (transportation to and from the airport is not included).
Delegates are encouraged to use public transport as much as possible.
ADVANCE PROGRAMME
Transportation
39
EBCC
10
European
Breast Cancer
Conference
EBCCouncil
9 - 11 MARCH
2016
AMSTERDAM
THE NETHERLANDS
Conference Secretariat:
c/o ECCO – the European CanCer Organisation
Avenue E. Mounier, 83
B-1200 Brussels
Belgium
Tel.: +32 (0) 2 775 02 01
Fax: + 32 (0) 2 775 02 00
[email protected]
www.ecco-org.eu/EBCC